VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q61114460  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241221010850.0
008     241221nneanz||abbn n and d
035 ‎‡a  (WKP)Q61114460‏
024 ‎‡a  0000-0002-0415-386X‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q61114460‏
100 0 ‎‡a  Jonathan D Smith‏ ‎‡9  nl‏ ‎‡9  es‏ ‎‡9  ast‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  জোনাথন ডি স্মিথ‏ ‎‡9  bn‏
400 0 ‎‡a  Jonathan D. Smith‏ ‎‡c  researcher ORCID ID = 0000-0002-0415-386X‏ ‎‡9  en‏
670 ‎‡a  Author's A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation‏
670 ‎‡a  Author's A simple and sensitive enzymatic method for cholesterol quantification in macrophages and foam cells‏
670 ‎‡a  Author's ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I‏
670 ‎‡a  Author's An abundant dysfunctional apolipoprotein A1 in human atheroma‏
670 ‎‡a  Author's Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation‏
670 ‎‡a  Author's CD6 expression has no effect on atherosclerosis in apolipoprotein E-deficient mice.‏
670 ‎‡a  Author's Changes in Whole Blood Gene Expression in Obese Subjects with Type 2 Diabetes Following Bariatric Surgery: a Pilot Study‏
670 ‎‡a  Author's Common Coding Variants in Are Associated With the Nav1.8 Late Current and Cardiac Conduction‏
670 ‎‡a  Author's Common variants in KCNN3 are associated with lone atrial fibrillation‏
670 ‎‡a  Author's Cyclosporin A traps ABCA1 at the plasma membrane and inhibits ABCA1-mediated lipid efflux to apolipoprotein A-I.‏
670 ‎‡a  Author's Deficiency of LRP8 in mice is associated with altered platelet function and prolonged time for in vivo thrombosis‏
670 ‎‡a  Author's Dysfunctional HDL as a diagnostic and therapeutic target‏
670 ‎‡a  Author's Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice‏
670 ‎‡a  Author's Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation.‏
670 ‎‡a  Author's Fifteen Genetic Loci Associated With the Electrocardiographic P Wave‏
670 ‎‡a  Author's Fine-mapping, novel loci identification, and SNP association transferability in a genome-wide association study of QRS duration in African Americans‏
670 ‎‡a  Author's First eight residues of apolipoprotein A-I mediate the C-terminus control of helical bundle unfolding and its lipidation‏
670 ‎‡a  Author's Free-cholesterol-mediated autophagy of ORMDL1 stimulates sphingomyelin biosynthesis‏
670 ‎‡a  Author's Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma‏
670 ‎‡a  Author's Gene-gene Interaction Analyses for Atrial Fibrillation‏
670 ‎‡a  Author's Genetic Interactions with Age, Sex, Body Mass Index, and Hypertension in Relation to Atrial Fibrillation: The AFGen Consortium‏
670 ‎‡a  Author's Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation‏
670 ‎‡a  Author's Genome-wide association meta-analysis of PR interval identifies 47 novel loci associated with atrial and atrioventricular electrical activity‏
670 ‎‡a  Author's Genome-wide association study of PR interval‏
670 ‎‡a  Author's Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease‏
670 ‎‡a  Author's HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation‏
670 ‎‡a  Author's High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies‏
670 ‎‡a  Author's High-density lipoprotein function, dysfunction, and reverse cholesterol transport‏
670 ‎‡a  Author's Human Macrophage Genetic Engineering‏
670 ‎‡a  Author's Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease‏
670 ‎‡a  Author's Identification of atherosclerosis-modifying genes: pathogenic insights and therapeutic potential‏
670 ‎‡a  Author's Identification of the cAMP-responsive enhancer of the murine ABCA1 gene: requirement for CREB1 and STAT3/4 elements‏
670 ‎‡a  Author's Independent susceptibility markers for atrial fibrillation on chromosome 4q25.‏
670 ‎‡a  Author's Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation‏
670 ‎‡a  Author's Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis‏
670 ‎‡a  Author's IRAK2 directs stimulus-dependent nuclear export of inflammatory mRNAs.‏
670 ‎‡a  Author's Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation.‏
670 ‎‡a  Author's Left atrial transcriptional changes associated with atrial fibrillation susceptibility and persistence‏
670 ‎‡a  Author's Meta-analysis identifies six new susceptibility loci for atrial fibrillation‏
670 ‎‡a  Author's Multi-ethnic genome-wide association study for atrial fibrillation‏
670 ‎‡a  Author's MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases‏
670 ‎‡a  Author's Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein‏
670 ‎‡a  Author's Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex‏
670 ‎‡a  Author's New role for histone deacetylase 9 in atherosclerosis and inflammation‏
670 ‎‡a  Author's Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese‏
670 ‎‡a  Author's PANCR, the PITX2 Adjacent Noncoding RNA, Is Expressed in Human Left Atria and Regulates PITX2c Expression‏
670 ‎‡a  Author's Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks‏
670 ‎‡a  Author's PI(4,5)P2 Is Translocated by ABCA1 to the Cell Surface Where It Mediates Apolipoprotein A1 Binding and Nascent HDL Assembly‏
670 ‎‡a  Author's Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro‏
670 ‎‡a  Author's Potential Use of Estrogen-Like Drugs for the Prevention of Alzheimer's Disease‏
670 ‎‡a  Author's PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity‏
670 ‎‡a  Author's Proteome Dynamics Reveals Pro-Inflammatory Remodeling of Plasma Proteome in a Mouse Model of NAFLD‏
670 ‎‡a  Author's Quantitative trait locus mapping identifies the Gpnmb gene as a modifier of mouse macrophage lysosome function‏
670 ‎‡a  Author's Reevaluation of the role of the multidrug-resistant P-glycoprotein in cellular cholesterol homeostasis‏
670 ‎‡a  Author's Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells‏
670 ‎‡a  Author's Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional‏
670 ‎‡a  Author's The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects‏
670 ‎‡a  Author's The Critical Role of IL-1 Receptor-Associated Kinase 4-Mediated NF-κB Activation in Modified Low-Density Lipoprotein-Induced Inflammatory Gene Expression and Atherosclerosis‏
670 ‎‡a  Author's The emergence of mouse models of atherosclerosis and their relevance to clinical research‏
670 ‎‡a  Author's The Upregulation of Integrin αDβ2‏
670 ‎‡a  Author's The Upregulation of Integrin αDβ2 (CD11d/CD18) on Inflammatory Macrophages Promotes Macrophage Retention in Vascular Lesions and Development of Atherosclerosis.‏
670 ‎‡a  Author's Thrombospondin-4 Regulates Vascular Inflammation and Atherogenesis‏
670 ‎‡a  Author's Transcriptome profile of macrophages from atherosclerosis-sensitive and atherosclerosis-resistant mice‏
670 ‎‡a  Author's Uptake of high-density lipoprotein by scavenger receptor class B type 1 is associated with prostate cancer proliferation and tumor progression in mice‏
670 ‎‡a  Author's Zymosan-mediated inflammation impairs in vivo reverse cholesterol transport‏
670 ‎‡a  Author's γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO‏
909 ‎‡a  (orcid) 000000020415386x‏ ‎‡9  1‏
912 ‎‡a  commonvariantsinkcnn3areassociatedwithloneatrialfibrillation‏ ‎‡A  Common variants in KCNN3 are associated with lone atrial fibrillation‏ ‎‡9  1‏
912 ‎‡a  metaanalysisidentifies6newsusceptibilitylociforatrialfibrillation‏ ‎‡A  Meta-analysis identifies six new susceptibility loci for atrial fibrillation‏ ‎‡9  1‏
912 ‎‡a  multiethnicgenomewideassociationstudyforatrialfibrillation‏ ‎‡A  Multi-ethnic genome-wide association study for atrial fibrillation‏ ‎‡9  1‏
912 ‎‡a  erratumlargescaleanalysesofcommonandrarevariantsidentify12newlociassociatedwithatrialfibrillation‏ ‎‡A  Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation.‏ ‎‡9  1‏
912 ‎‡a  genegeneinteractionanalysesforatrialfibrillation‏ ‎‡A  Gene-gene Interaction Analyses for Atrial Fibrillation‏ ‎‡9  1‏
912 ‎‡a  geneticinteractionswithagesexbodymassindexandhypertensioninrelationtoatrialfibrillationtheafgenconsortium‏ ‎‡A  Genetic Interactions with Age, Sex, Body Mass Index, and Hypertension in Relation to Atrial Fibrillation: The AFGen Consortium‏ ‎‡9  1‏
912 ‎‡a  novelgeneticmarkersassociatewithatrialfibrillationriskineuropeansandjapanese‏ ‎‡A  Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese‏ ‎‡9  1‏
912 ‎‡a  genomewideassociationmetaanalysisofprintervalidentifies47novellociassociatedwithatrialandatrioventricularelectricalactivity‏ ‎‡A  Genome-wide association meta-analysis of PR interval identifies 47 novel loci associated with atrial and atrioventricular electrical activity‏ ‎‡9  1‏
912 ‎‡a  genomewideassociationstudyofprinterval‏ ‎‡A  Genome-wide association study of PR interval‏ ‎‡9  1‏
912 ‎‡a  printervalgenomewideassociationmetaanalysisidentifies50lociassociatedwithatrialandatrioventricularelectricalactivity‏ ‎‡A  PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity‏ ‎‡9  1‏
912 ‎‡a  largescaleanalysesofcommonandrarevariantsidentify12newlociassociatedwithatrialfibrillation‏ ‎‡A  Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation.‏ ‎‡9  1‏
919 ‎‡a  cd6expressionhasnoeffectonatherosclerosisinapolipoproteinedeficientmice‏ ‎‡A  CD6 expression has no effect on atherosclerosis in apolipoprotein E-deficient mice.‏ ‎‡9  1‏
919 ‎‡a  changesinwholebloodgeneexpressioninobesesubjectswithtype2diabetesfollowingbariatricsurgeryapilotstudy‏ ‎‡A  Changes in Whole Blood Gene Expression in Obese Subjects with Type 2 Diabetes Following Bariatric Surgery: a Pilot Study‏ ‎‡9  1‏
919 ‎‡a  leftatrialtranscriptionalchangesassociatedwithatrialfibrillationsusceptibilityandpersistence‏ ‎‡A  Left atrial transcriptional changes associated with atrial fibrillation susceptibility and persistence‏ ‎‡9  1‏
919 ‎‡a  commoncodingvariantsinareassociatedwiththenav18latecurrentandcardiacconduction‏ ‎‡A  Common Coding Variants in Are Associated With the Nav1.8 Late Current and Cardiac Conduction‏ ‎‡9  1‏
919 ‎‡a  reevaluationoftheroleofthemultidrugresistantpglycoproteinincellularcholesterolhomeostasis‏ ‎‡A  Reevaluation of the role of the multidrug-resistant P-glycoprotein in cellular cholesterol homeostasis‏ ‎‡9  1‏
919 ‎‡a  cyclosporinatrapsabca1attheplasmamembraneandinhibitsabca1mediatedlipideffluxtoapolipoproteina1‏ ‎‡A  Cyclosporin A traps ABCA1 at the plasma membrane and inhibits ABCA1-mediated lipid efflux to apolipoprotein A-I.‏ ‎‡9  1‏
919 ‎‡a  deficiencyoflrp8inmiceisassociatedwithalteredplateletfunctionandprolongedtimeforinvivothrombosis‏ ‎‡A  Deficiency of LRP8 in mice is associated with altered platelet function and prolonged time for in vivo thrombosis‏ ‎‡9  1‏
919 ‎‡a  dysfunctionalhdlasadiagnosticandtherapeutictarget‏ ‎‡A  Dysfunctional HDL as a diagnostic and therapeutic target‏ ‎‡9  1‏
919 ‎‡a  effectsofnativeandmyeloperoxidasemodifiedapolipoproteina1onreversecholesteroltransportandatherosclerosisinmice‏ ‎‡A  Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice‏ ‎‡9  1‏
919 ‎‡a  myd88dependentinterplaybetweenmyeloidandendothelialcellsintheinitiationandprogressionofobesityassociatedinflammatorydiseases‏ ‎‡A  MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases‏ ‎‡9  1‏
919 ‎‡a  severehypercholesterolemiaandatherosclerosisinapolipoproteinedeficientmicecreatedbyhomologousrecombinationinescells‏ ‎‡A  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells‏ ‎‡9  1‏
919 ‎‡a  thrombospondin4regulatesvascularinflammationandatherogenesis‏ ‎‡A  Thrombospondin-4 Regulates Vascular Inflammation and Atherogenesis‏ ‎‡9  1‏
919 ‎‡a  15geneticlociassociatedwiththeelectrocardiographicpwave‏ ‎‡A  Fifteen Genetic Loci Associated With the Electrocardiographic P Wave‏ ‎‡9  1‏
919 ‎‡a  myeloperoxidaseinflammationanddysfunctionalhighdensitylipoprotein‏ ‎‡A  Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein‏ ‎‡9  1‏
919 ‎‡a  finemappingnovellociidentificationandsnpassociationtransferabilityinagenomewideassociationstudyofqrsdurationinafricanamericans‏ ‎‡A  Fine-mapping, novel loci identification, and SNP association transferability in a genome-wide association study of QRS duration in African Americans‏ ‎‡9  1‏
919 ‎‡a  18residuesofapolipoproteina1mediatethe100terminuscontrolofhelicalbundleunfoldinganditslipidation‏ ‎‡A  First eight residues of apolipoprotein A-I mediate the C-terminus control of helical bundle unfolding and its lipidation‏ ‎‡9  1‏
919 ‎‡a  myeloperoxidaseparaoxonase1andhdlformafunctionalternarycomplex‏ ‎‡A  Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex‏ ‎‡9  1‏
919 ‎‡a  sitespecificnitrationofapolipoproteina1attyrosine166isbothabundantwithinhumanatheroscleroticplaqueanddysfunctional‏ ‎‡A  Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional‏ ‎‡9  1‏
919 ‎‡a  freecholesterolmediatedautophagyoformdl1stimulatessphingomyelinbiosynthesis‏ ‎‡A  Free-cholesterol-mediated autophagy of ORMDL1 stimulates sphingomyelin biosynthesis‏ ‎‡9  1‏
919 ‎‡a  functionanddistributionofapolipoproteina1inthearterywallaremarkedlydistinctfromthoseinplasma‏ ‎‡A  Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma‏ ‎‡9  1‏
919 ‎‡a  newroleforhistonedeacetylase9inatherosclerosisandinflammation‏ ‎‡A  New role for histone deacetylase 9 in atherosclerosis and inflammation‏ ‎‡9  1‏
919 ‎‡a  cardioprotectiveproteinapolipoproteina1promotespotentantitumorigeniceffects‏ ‎‡A  The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects‏ ‎‡9  1‏
919 ‎‡a  transcriptomeprofileofmacrophagesfromatherosclerosissensitiveandatherosclerosisresistantmice‏ ‎‡A  Transcriptome profile of macrophages from atherosclerosis-sensitive and atherosclerosis-resistant mice‏ ‎‡9  1‏
919 ‎‡a  γbutyrobetaineisaproatherogenicintermediateingutmicrobialmetabolismof50carnitinetotmao‏ ‎‡A  γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO‏ ‎‡9  1‏
919 ‎‡a  geneticsusceptibilityforatrialfibrillationinpatientsundergoingatrialfibrillationablation‏ ‎‡A  Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation‏ ‎‡9  1‏
919 ‎‡a  pancrthepitx2adjacentnoncodingrnaisexpressedinhumanleftatriaandregulatespitx2cexpression‏ ‎‡A  PANCR, the PITX2 Adjacent Noncoding RNA, Is Expressed in Human Left Atria and Regulates PITX2c Expression‏ ‎‡9  1‏
919 ‎‡a  gutflorametabolismofphosphatidylcholinepromotescardiovasculardisease‏ ‎‡A  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease‏ ‎‡9  1‏
919 ‎‡a  paradoxicalassociationofenhancedcholesteroleffluxwithincreasedincidentcardiovascularrisks‏ ‎‡A  Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks‏ ‎‡9  1‏
919 ‎‡a  criticalroleofil1receptorassociatedkinase4mediatednfκbactivationinmodifiedlowdensitylipoproteininducedinflammatorygeneexpressionandatherosclerosis‏ ‎‡A  The Critical Role of IL-1 Receptor-Associated Kinase 4-Mediated NF-κB Activation in Modified Low-Density Lipoprotein-Induced Inflammatory Gene Expression and Atherosclerosis‏ ‎‡9  1‏
919 ‎‡a  hdlboundsphingosine1phosphateactsasabiasedagonistfortheendothelialcellreceptors1p1tolimitvascularinflammation‏ ‎‡A  HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation‏ ‎‡9  1‏
919 ‎‡a  highdensitylipoproteinandatherosclerosisregressionevidencefrompreclinicalandclinicalstudies‏ ‎‡A  High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies‏ ‎‡9  1‏
919 ‎‡a  pi45p2istranslocatedbyabca1tothecellsurfacewhereitmediatesapolipoproteina1bindingandnascenthdlassembly‏ ‎‡A  PI(4,5)P2 Is Translocated by ABCA1 to the Cell Surface Where It Mediates Apolipoprotein A1 Binding and Nascent HDL Assembly‏ ‎‡9  1‏
919 ‎‡a  emergenceofmousemodelsofatherosclerosisandtheirrelevancetoclinicalresearch‏ ‎‡A  The emergence of mouse models of atherosclerosis and their relevance to clinical research‏ ‎‡9  1‏
919 ‎‡a  uptakeofhighdensitylipoproteinbyscavengerreceptorclassbtype1isassociatedwithprostatecancerproliferationandtumorprogressioninmice‏ ‎‡A  Uptake of high-density lipoprotein by scavenger receptor class B type 1 is associated with prostate cancer proliferation and tumor progression in mice‏ ‎‡9  1‏
919 ‎‡a  highdensitylipoproteinfunctiondysfunctionandreversecholesteroltransport‏ ‎‡A  High-density lipoprotein function, dysfunction, and reverse cholesterol transport‏ ‎‡9  1‏
919 ‎‡a  humanmacrophagegeneticengineering‏ ‎‡A  Human Macrophage Genetic Engineering‏ ‎‡9  1‏
919 ‎‡a  polymorphisminthehumanapolipoproteina1genepromoterregionassociationoftheminorallelewithdecreasedproductionrateinvivoandpromoteractivityinvitro‏ ‎‡A  Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro‏ ‎‡9  1‏
919 ‎‡a  identificationofapolipoprotein500asacardioprotectivegeneusingamousemodeloflethalatheroscleroticcoronaryarterydisease‏ ‎‡A  Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease‏ ‎‡9  1‏
919 ‎‡a  identificationofatherosclerosismodifyinggenespathogenicinsightsandtherapeuticpotential‏ ‎‡A  Identification of atherosclerosis-modifying genes: pathogenic insights and therapeutic potential‏ ‎‡9  1‏
919 ‎‡a  potentialuseofestrogenlikedrugsforthepreventionofalzheimersdisease‏ ‎‡A  Potential Use of Estrogen-Like Drugs for the Prevention of Alzheimer's Disease‏ ‎‡9  1‏
919 ‎‡a  identificationofthecampresponsiveenhancerofthemurineabca1generequirementforcreb1andstat34elements‏ ‎‡A  Identification of the cAMP-responsive enhancer of the murine ABCA1 gene: requirement for CREB1 and STAT3/4 elements‏ ‎‡9  1‏
919 ‎‡a  independentsusceptibilitymarkersforatrialfibrillationonchromosome4q25‏ ‎‡A  Independent susceptibility markers for atrial fibrillation on chromosome 4q25.‏ ‎‡9  1‏
919 ‎‡a  upregulationofintegrinαdβ2‏ ‎‡A  The Upregulation of Integrin αDβ2‏ ‎‡9  1‏
919 ‎‡a  integratinggenetictranscriptionalandfunctionalanalysestoidentify5novelgenesforatrialfibrillation‏ ‎‡A  Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation‏ ‎‡9  1‏
919 ‎‡a  commonconnexin40genepromotervariantaffectsconnexin40expressioninhumanatriaandisassociatedwithatrialfibrillation‏ ‎‡A  A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation‏ ‎‡9  1‏
919 ‎‡a  intestinalmicrobiotametabolismof50carnitineanutrientinredmeatpromotesatherosclerosis‏ ‎‡A  Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis‏ ‎‡9  1‏
919 ‎‡a  proteomedynamicsrevealsproinflammatoryremodelingofplasmaproteomeinamousemodelofnafld‏ ‎‡A  Proteome Dynamics Reveals Pro-Inflammatory Remodeling of Plasma Proteome in a Mouse Model of NAFLD‏ ‎‡9  1‏
919 ‎‡a  simpleandsensitiveenzymaticmethodforcholesterolquantificationinmacrophagesandfoamcells‏ ‎‡A  A simple and sensitive enzymatic method for cholesterol quantification in macrophages and foam cells‏ ‎‡9  1‏
919 ‎‡a  abca1mediatesconcurrentcholesterolandphospholipideffluxtoapolipoproteina1‏ ‎‡A  ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I‏ ‎‡9  1‏
919 ‎‡a  irak2directsstimulusdependentnuclearexportofinflammatorymrnas‏ ‎‡A  IRAK2 directs stimulus-dependent nuclear export of inflammatory mRNAs.‏ ‎‡9  1‏
919 ‎‡a  abundantdysfunctionalapolipoproteina1inhumanatheroma‏ ‎‡A  An abundant dysfunctional apolipoprotein A1 in human atheroma‏ ‎‡9  1‏
919 ‎‡a  associationbetweentitinlossoffunctionvariantsandearlyonsetatrialfibrillation‏ ‎‡A  Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation‏ ‎‡9  1‏
919 ‎‡a  quantitativetraitlocusmappingidentifiesthegpnmbgeneasamodifierofmousemacrophagelysosomefunction‏ ‎‡A  Quantitative trait locus mapping identifies the Gpnmb gene as a modifier of mouse macrophage lysosome function‏ ‎‡9  1‏
919 ‎‡a  upregulationofintegrinαdβ2cd11dcd18oninflammatorymacrophagespromotesmacrophageretentioninvascularlesionsanddevelopmentofatherosclerosis‏ ‎‡A  The Upregulation of Integrin αDβ2 (CD11d/CD18) on Inflammatory Macrophages Promotes Macrophage Retention in Vascular Lesions and Development of Atherosclerosis.‏ ‎‡9  1‏
919 ‎‡a  zymosanmediatedinflammationimpairsinvivoreversecholesteroltransport‏ ‎‡A  Zymosan-mediated inflammation impairs in vivo reverse cholesterol transport‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  LC|no 00046767‏
996 ‎‡2  BIBSYS|4003220‏
996 ‎‡2  J9U|987012722499005171‏
996 ‎‡2  SUDOC|182800520‏
996 ‎‡2  DNB|1053161972‏
996 ‎‡2  ISNI|0000000418546765‏
996 ‎‡2  CAOONL|ncf10933919‏
996 ‎‡2  NLA|000061458442‏
996 ‎‡2  NTA|229307809‏
996 ‎‡2  NII|DA17772336‏
996 ‎‡2  BIBSYS|12001927‏
996 ‎‡2  BNF|14002814‏
996 ‎‡2  ISNI|0000000064068881‏
996 ‎‡2  SELIBR|m55cmqsmkpws360h‏
996 ‎‡2  ISNI|0000000023653515‏
996 ‎‡2  BIBSYS|90113625‏
996 ‎‡2  J9U|987007351621205171‏
996 ‎‡2  LIH|LNB:C_k__d_7;=B_p_‏
996 ‎‡2  LC|n 83206591‏
996 ‎‡2  NUKAT|n 2004092068‏
996 ‎‡2  NII|DA03474500‏
996 ‎‡2  BNF|16750164‏
996 ‎‡2  B2Q|0000083687‏
996 ‎‡2  ISNI|0000000038612046‏
996 ‎‡2  SUDOC|244835497‏
996 ‎‡2  ISNI|0000000388638377‏
996 ‎‡2  LC|n 80151626‏
996 ‎‡2  BNCHL|10000000000000000170560‏
996 ‎‡2  J9U|987007433542305171‏
996 ‎‡2  LC|no2015052366‏
996 ‎‡2  LC|n 2010048862‏
996 ‎‡2  J9U|987007442750905171‏
996 ‎‡2  LC|nr 95000804‏
996 ‎‡2  LC|nr 93020262‏
996 ‎‡2  BNF|17991959‏
996 ‎‡2  NTA|070047537‏
996 ‎‡2  LC|no2009018319‏
996 ‎‡2  ISNI|0000000083280992‏
996 ‎‡2  ISNI|0000000077364719‏
996 ‎‡2  BIBSYS|90606915‏
996 ‎‡2  DNB|118797689‏
996 ‎‡2  LC|no 93019122‏
996 ‎‡2  CAOONL|ncf10028114‏
996 ‎‡2  ISNI|0000000042539953‏
996 ‎‡2  NLA|000035438376‏
996 ‎‡2  DNB|12094152X‏
996 ‎‡2  LC|n 96025598‏
996 ‎‡2  ISNI|0000000068911848‏
996 ‎‡2  LC|n 84134059‏
996 ‎‡2  PLWABN|9810574858305606‏
996 ‎‡2  J9U|987012722627305171‏
996 ‎‡2  CAOONL|ncf10044369‏
996 ‎‡2  ISNI|0000000046630308‏
996 ‎‡2  LC|n 2014041729‏
996 ‎‡2  LC|n 81055156‏
996 ‎‡2  NKC|jn19990005209‏
996 ‎‡2  CAOONL|ncf10051559‏
996 ‎‡2  BIBSYS|2052430‏
996 ‎‡2  JPG|500019843‏
996 ‎‡2  NTA|091969549‏
996 ‎‡2  BAV|495_390179‏
996 ‎‡2  J9U|987007434180605171‏
996 ‎‡2  NTA|393617742‏
996 ‎‡2  SUDOC|121714829‏
996 ‎‡2  ISNI|0000000366962344‏
996 ‎‡2  LC|n 92071293‏
996 ‎‡2  LC|no2015034254‏
996 ‎‡2  SUDOC|270806474‏
996 ‎‡2  DNB|124991343‏
996 ‎‡2  LC|no 99051921‏
996 ‎‡2  ISNI|0000000053205908‏
996 ‎‡2  NUKAT|n 2006141288‏
996 ‎‡2  SUDOC|176152687‏
996 ‎‡2  NKC|pna2016913533‏
996 ‎‡2  LC|nr 99025239‏
996 ‎‡2  LC|nr 91044457‏
996 ‎‡2  LC|nb 91312363‏
996 ‎‡2  BLBNB|000553101‏
996 ‎‡2  NTA|339748494‏
996 ‎‡2  ISNI|0000000437210319‏
996 ‎‡2  LC|n 88126531‏
996 ‎‡2  LC|n 85098735‏
996 ‎‡2  PLWABN|9810568440705606‏
996 ‎‡2  NYNYRILM|356721‏
996 ‎‡2  RERO|A022957834‏
996 ‎‡2  SUDOC|140857168‏
996 ‎‡2  LC|no2024112103‏
996 ‎‡2  LC|n 85351465‏
996 ‎‡2  ISNI|0000000067494237‏
996 ‎‡2  LC|n 96012912‏
996 ‎‡2  NTA|073267384‏
996 ‎‡2  NUKAT|n 2004252609‏
996 ‎‡2  LC|nb2019014295‏
996 ‎‡2  NTA|182560880‏
996 ‎‡2  LC|n 2017024648‏
996 ‎‡2  LC|no2009082429‏
996 ‎‡2  J9U|987007605756105171‏
996 ‎‡2  NTA|087347148‏
996 ‎‡2  NTA|070158274‏
996 ‎‡2  ISNI|0000000082147858‏
996 ‎‡2  NLA|000036517360‏
996 ‎‡2  LC|nr2002002362‏
996 ‎‡2  J9U|987007416047205171‏
996 ‎‡2  ISNI|0000000043656019‏
996 ‎‡2  LC|no 94012835‏
996 ‎‡2  LC|nr2003041237‏
996 ‎‡2  LC|n 92074049‏
996 ‎‡2  LC|n 2004108835‏
996 ‎‡2  SELIBR|200779‏
996 ‎‡2  ISNI|0000000066470591‏
996 ‎‡2  LC|nb2002047553‏
996 ‎‡2  LC|no2004091899‏
996 ‎‡2  ISNI|0000000109225968‏
996 ‎‡2  LC|n 2008034837‏
996 ‎‡2  JPG|500084191‏
996 ‎‡2  BNCHL|10000000000000000144579‏
996 ‎‡2  ISNI|0000000031466429‏
996 ‎‡2  LC|no 97037302‏
996 ‎‡2  NKC|mzk2014843264‏
996 ‎‡2  J9U|987007358152805171‏
996 ‎‡2  LC|no2017011287‏
996 ‎‡2  LC|nr2002003988‏
996 ‎‡2  LC|nb 91524207‏
996 ‎‡2  LC|n 2019053611‏
996 ‎‡2  CAOONL|ncf10529384‏
996 ‎‡2  ISNI|0000000083001703‏
996 ‎‡2  ISNI|0000000393699924‏
996 ‎‡2  LC|no2020026363‏
996 ‎‡2  ISNI|000000012062453X‏
996 ‎‡2  NKC|xx0234390‏
996 ‎‡2  ISNI|0000000055621585‏
996 ‎‡2  NTA|243055102‏
996 ‎‡2  NKC|jo2016897394‏
996 ‎‡2  RERO|A025511720‏
996 ‎‡2  ISNI|0000000021919623‏
996 ‎‡2  NSK|000017549‏
996 ‎‡2  ISNI|0000000120145838‏
996 ‎‡2  BNF|12466786‏
996 ‎‡2  DNB|1204277664‏
996 ‎‡2  LC|nr 94039623‏
996 ‎‡2  ISNI|0000000048811313‏
996 ‎‡2  NLA|000035747782‏
996 ‎‡2  ISNI|0000000079229641‏
996 ‎‡2  LC|n 82098215‏
996 ‎‡2  NTA|072711337‏
996 ‎‡2  ISNI|0000000114950152‏
996 ‎‡2  RERO|A003839527‏
996 ‎‡2  ISNI|0000000040729577‏
996 ‎‡2  SZ|1236217217‏
996 ‎‡2  NUKAT|n 2023166765‏
996 ‎‡2  SUDOC|059554878‏
996 ‎‡2  LC|n 97866648‏
996 ‎‡2  RERO|A003839520‏
996 ‎‡2  ISNI|0000000117595993‏
996 ‎‡2  RERO|A003839529‏
996 ‎‡2  CAOONL|ncf10315071‏
996 ‎‡2  LC|n 85158351‏
996 ‎‡2  LC|no2006061251‏
996 ‎‡2  BIBSYS|90385342‏
996 ‎‡2  N6I|vtls002288605‏
996 ‎‡2  LC|nb2011011021‏
996 ‎‡2  NTA|339722118‏
996 ‎‡2  ISNI|0000000076774556‏
996 ‎‡2  BNC|981058522660606706‏
996 ‎‡2  NTA|072598549‏
996 ‎‡2  DNB|101273037‏
996 ‎‡2  ISNI|0000000023502506‏
996 ‎‡2  BIBSYS|5099108‏
996 ‎‡2  BIBSYS|90853216‏
996 ‎‡2  LC|nb2003007264‏
996 ‎‡2  NII|DA00596647‏
996 ‎‡2  NKC|utb2012706078‏
996 ‎‡2  LC|n 2010160018‏
996 ‎‡2  LC|nb2014028766‏
996 ‎‡2  CAOONL|ncf11302551‏
996 ‎‡2  NKC|jo20231201383‏
996 ‎‡2  LC|no2010033841‏
996 ‎‡2  RERO|A022966454‏
996 ‎‡2  LC|no2008164862‏
996 ‎‡2  ISNI|0000000083622534‏
996 ‎‡2  NTA|068500602‏
996 ‎‡2  PLWABN|9810606059005606‏
996 ‎‡2  LC|n 85252219‏
996 ‎‡2  RERO|A011619772‏
996 ‎‡2  J9U|987007438016205171‏
996 ‎‡2  RERO|A012488324‏
996 ‎‡2  ISNI|0000000116535673‏
996 ‎‡2  ISNI|0000000080912800‏
996 ‎‡2  BNF|14430931‏
996 ‎‡2  LC|no2015158742‏
996 ‎‡2  SIMACOB|33923171‏
996 ‎‡2  BIBSYS|90901978‏
996 ‎‡2  NUKAT|n 2022131926‏
996 ‎‡2  LC|n 2006078076‏
996 ‎‡2  LC|nb2014014489‏
996 ‎‡2  BAV|495_354894‏
996 ‎‡2  LC|n 96027022‏
996 ‎‡2  J9U|987007308254505171‏
996 ‎‡2  LC|no2023035241‏
996 ‎‡2  NTA|115862854‏
996 ‎‡2  NII|DA01657612‏
996 ‎‡2  LC|no2003123663‏
996 ‎‡2  RERO|A017689650‏
996 ‎‡2  NTA|301093768‏
996 ‎‡2  DNB|1088321054‏
996 ‎‡2  J9U|987007270643005171‏
996 ‎‡2  ISNI|0000000359123358‏
996 ‎‡2  NTA|071554394‏
996 ‎‡2  JPG|500083840‏
996 ‎‡2  LIH|LNB:C_c_NO;=BZ‏
996 ‎‡2  NKC|mzk2009512875‏
996 ‎‡2  ISNI|0000000110396078‏
996 ‎‡2  CAOONL|ncf10373082‏
996 ‎‡2  NII|DA18696856‏
996 ‎‡2  LC|no2015098868‏
996 ‎‡2  LC|n 2006060719‏
996 ‎‡2  LC|n 87946939‏
996 ‎‡2  LC|n 97116158‏
996 ‎‡2  DNB|139395210‏
996 ‎‡2  PLWABN|9810546843105606‏
996 ‎‡2  NKC|vse2010576484‏
996 ‎‡2  NUKAT|n 2008106388‏
996 ‎‡2  ISNI|0000000081974093‏
996 ‎‡2  N6I|vtls001107582‏
996 ‎‡2  ISNI|000000004644867X‏
996 ‎‡2  BNF|17804101‏
996 ‎‡2  CAOONL|ncf12132908‏
996 ‎‡2  CAOONL|ncf10642686‏
996 ‎‡2  LC|nb2011016480‏
996 ‎‡2  BIBSYS|15037572‏
996 ‎‡2  BIBSYS|90396873‏
996 ‎‡2  ISNI|0000000394125121‏
996 ‎‡2  N6I|vtls000044516‏
996 ‎‡2  BNF|12156010‏
996 ‎‡2  NUKAT|n 2005136601‏
996 ‎‡2  ISNI|0000000380370409‏
996 ‎‡2  RERO|A011617931‏
996 ‎‡2  BIBSYS|90527686‏
996 ‎‡2  LC|n 82274675‏
996 ‎‡2  W2Z|90678482‏
996 ‎‡2  LC|n 88090548‏
996 ‎‡2  ISNI|0000000077208054‏
996 ‎‡2  J9U|987007426658005171‏
996 ‎‡2  LC|n 80156730‏
996 ‎‡2  BIBSYS|90593087‏
996 ‎‡2  SUDOC|030795389‏
996 ‎‡2  RERO|A003839010‏
996 ‎‡2  DNB|1157673449‏
996 ‎‡2  ISNI|0000000045194903‏
996 ‎‡2  LC|no2017048609‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏